MYCELX Technologies Corporation (AIM:MYX)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 13.52M +136.2% |
| Revenue (ttm) | 9.18M +296.4% |
| Net Income | 614.27K |
| EPS | 0.02 |
| Shares Out | 24.36M |
| PE Ratio | 25.50 |
| Forward PE | 175.08 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 10,000 |
| Open | 55.50 |
| Previous Close | 55.00 |
| Day's Range | 55.50 - 55.50 |
| 52-Week Range | 20.10 - 68.00 |
| Beta | 1.22 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 24, 2026 |
About MYCELX Technologies
MYCELX Technologies Corporation, a clean water technology company, provides water treatment solutions to the PFAS remediation and produced water markets in the Nigeria, Middle East, the United States, Australia, and internationally. The company sells and leases its equipment; and sells filtration media. It also provides clean water technology equipment and related services to the oil and gas, power, marine and heavy manufacturing sectors. The company was incorporated in 1994 and is headquartered in Norcross, Georgia. [Read more]
News
AIM Market Roundup: Trellus Health, Genedrive, Mycelx
Trellus Health, Genedrive, Mycelx are today's top risers, while CPP, PetroTal take the biggest fall on London's AIM market
Mycelx expects drilling boom to fuel growth
Mycelx Technologies is well positioned to benefit from growth in the US oil drilling sector and potential from new multi-billion PFAS industry